Tower Research Capital (TRC)’s Xtant Medical Holdings XTNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.38K | Buy |
10,398
+3,010
| +41% | +$1.44K | ﹤0.01% | 4394 |
|
|
2026
Q1 | $4.12K | Buy |
7,388
+2,772
| +60% | +$1.71K | ﹤0.01% | 4228 |
|
|
2025
Q4 | $3.62K | Buy |
4,616
+1,046
| +29% | +$760 | ﹤0.01% | 4339 |
|
|
2025
Q3 | $2.32K | Sell |
3,570
-2,213
| -38% | -$1.4K | ﹤0.01% | 4650 |
|
|
2025
Q2 | $4.27K | Sell |
5,783
-86
| -1% | -$49 | ﹤0.01% | 4350 |
|
|
2025
Q1 | $2.76K | Sell |
5,869
-10,206
| -63% | -$5.37K | ﹤0.01% | 4511 |
|
|
2024
Q4 | $7.12K | Buy |
16,075
+10,758
| +202% | +$5.21K | ﹤0.01% | 4103 |
|
|
2024
Q3 | $3.59K | Sell |
5,317
-9,470
| -64% | -$6.26K | ﹤0.01% | 4812 |
|
|
2024
Q2 | $9.32K | Buy |
14,787
+12,525
| +554% | +$10K | ﹤0.01% | 4262 |
|
|
2024
Q1 | $2.65K | Sell |
2,262
-8,086
| -78% | -$8.86K | ﹤0.01% | 5003 |
|
|
2023
Q4 | $11.7K | Sell |
10,348
-3,745
| -27% | -$4.4K | ﹤0.01% | 4110 |
|
|
2023
Q3 | $15.5K | Buy |
14,093
+7,080
| +101% | +$7.6K | ﹤0.01% | 3612 |
|
|
2023
Q2 | $6.52K | Buy |
7,013
+1,734
| +33% | +$1.16K | ﹤0.01% | 4690 |
|
|
2023
Q1 | $3K | Buy |
+5,279
| New | +$3.85K | ﹤0.01% | 5256 |
|
|
2022
Q4 | – | Sell |
-11,914
| Closed | -$9K | – | 6458 |
|
|
2022
Q3 | $9K | Buy |
11,914
+988
| +9% | +$541 | ﹤0.01% | 4707 |
|
|
2022
Q2 | $6K | Buy |
10,926
+3,810
| +54% | +$2.26K | ﹤0.01% | 4964 |
|
|
2022
Q1 | $5K | Sell |
7,116
-3,153
| -31% | -$2.06K | ﹤0.01% | 5121 |
|
|
2021
Q4 | $6K | Sell |
10,269
-21,393
| -68% | -$20.2K | ﹤0.01% | 5075 |
|
|
2021
Q3 | $35K | Buy |
31,662
+23,432
| +285% | +$30.5K | ﹤0.01% | 3249 |
|
|
2021
Q2 | $13K | Sell |
8,230
-44,410
| -84% | -$79K | ﹤0.01% | 4247 |
|
|
2021
Q1 | $124K | Buy |
52,640
+31,033
| +144% | +$66.3K | ﹤0.01% | 2422 |
|
|
2020
Q4 | $26K | Buy |
21,607
+8,401
| +64% | +$10.8K | ﹤0.01% | 3703 |
|
|
2020
Q3 | $11K | Buy |
+13,206
| New | +$12.9K | ﹤0.01% | 4074 |
|
|
2016
Q3 | – | Sell |
-39
| Closed | -$1K | – | 4557 |
|
|
2016
Q2 | $1K | Buy |
39
+8
| +26% | +$206 | ﹤0.01% | 4230 |
|
|
2016
Q1 | $1K | Buy |
+31
| New | +$990 | ﹤0.01% | 3812 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5126 |
|
|
2015
Q2 | – | Sell |
-50
| Closed | -$2K | – | 5121 |
|
|
2015
Q1 | $2K | Buy |
+50
| New | +$2.01K | ﹤0.01% | 3844 |
|
|
2014
Q4 | – | Sell |
-27
| Closed | -$1K | – | 4772 |
|
|
2014
Q3 | $1K | Buy |
+27
| New | +$1.79K | ﹤0.01% | 4171 |
|
Other funds holding XTNT
AIC
NCNMGF
Tower Research Capital (TRC)'s XTNT Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its Xtant Medical Holdings (XTNT) stake by 41% in Q2 2026, buying an estimated $1.44K and bringing the position to 10,398 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4394.
Tower Research Capital (TRC) first reported a position in XTNT in Q3 2014 and has held it in 27 quarters since. The position peaked at $124K in Q1 2021. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.
- Tower Research Capital (TRC) held 10,398 shares of Xtant Medical Holdings worth $4.38K as of Q2 2026.
- Tower Research Capital (TRC) bought 3,010 Xtant Medical Holdings shares in Q2 2026, an estimated $1.44K.
- Xtant Medical Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4394 holding.
- Tower Research Capital (TRC) first reported a position in Xtant Medical Holdings in Q3 2014 and has held it in 27 quarters since.
- Tower Research Capital (TRC)'s Xtant Medical Holdings position peaked at $124K in Q1 2021.
- 32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.